Tumor-Related Gene Changes in Immunosuppressive Syrian Hamster Cholangiocarcinoma
The results of a previous study demonstrated that prednisolone enhanced cholangiocarcinogenesis. Therefore, to clarify molecular changes during immunosuppressive cholangiocarcinogenesis, Syrian hamsters were divided into 8 groups: uninfected controls; immunosuppressed Syrian hamsters using prednisol...
Saved in:
Published in | Pathology oncology research Vol. 19; no. 4; pp. 785 - 794 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Dordrecht
Springer Netherlands
01.10.2013
Springer Nature B.V |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The results of a previous study demonstrated that prednisolone enhanced cholangiocarcinogenesis. Therefore, to clarify molecular changes during immunosuppressive cholangiocarcinogenesis, Syrian hamsters were divided into 8 groups: uninfected controls; immunosuppressed Syrian hamsters using prednisolone (P); normal Syrian hamsters administered
N
-nitrosodimethylamine (ND); immunosuppressed Syrian hamsters administered
N
-nitrosodimethylamine (ND
is
); normal Syrian hamsters infected with
Opisthorchis viverrini
(OV); immunosuppressed Syrian hamsters infected with
O. viverrini
(OV
is
); normal Syrian hamsters infected with
O. viverrini
and administered
N
-nitrosodimethylamine (CCA); and immunosuppressed Syrian hamsters infected with
O. viverrini
and administered
N
-nitrosodimethylamine (CCA
is
). Syrian hamster livers were used for analysis of tumor-related gene expression and immunohistochemistry through cytokeratin 19 (CK19) and proliferating cell nuclear antigen (PCNA) staining. The tumor-related gene expression results show that CCA
is
groups at all time points exhibited upregulation of COX-2, IL-6, SOD1, CAT and iNOS and downregulation of p53, which correlated with the predominant expression of CK19 and PCNA in liver tissue. These results suggest that prednisolone enhances cholangiocarcinoma development, which was confirmed by molecular changes. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 |
ISSN: | 1219-4956 1532-2807 |
DOI: | 10.1007/s12253-013-9645-x |